Last updated on December 2019

A Study To Evaluate PF-06730512 In Adults With Primary Focal Segmental Glomerulosclerosis

Brief description of study

The purpose of this Phase 2 adaptive study is to evaluate the efficacy, safety, tolerability and pharmacokinetics of PF-06730512 following multiple intravenous infusion in adult subjects with primary FSGS.

Clinical Study Identifier: NCT03448692

Find a site near you

Start Over